Research Roundup: Novel antibiotic research, RSV vaccine efficacy, HPV testing access agreement
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Twenty years after the approval of the first HPV vaccine, a game-changing tool that has helped dramatically reduce rates of HPV infection and cervical cancer around the world, researchers are now developing new tools to address remaining gaps in cervical cancer screening, diagnosis, and care.
In recognition of Father's Day, GHTC is highlighting the need for and progress in advancing novel male contraceptive innovation.
Preeclampsia affects millions of pregnancies around the world, especially in low- and middle-income countries, but despite its global impact, preeclampsia remains under-researched and under-represented in the health innovation pipeline, creating critical gaps in screening, diagnosis, and treatment. New tools in the pipeline could help close these gaps in care worldwide.